Meanwhile, the absence of LSD1 promotes TGF-β expression in melanoma and colorectal cancer (CRC) cells, and the up-regulated TGF-β counteracts the anti-tumor effects of LSD1 deletion-induced T cell infiltration by inhibiting the cytotoxicity of CD8+ T cells within the tumor. This evidence concerns the gene CD8A and colorectal carcinoma.